13G Filing: Viking Global and Deciphera Pharmaceuticals LLC (DCPH)

Page 12 of 16

Page 12 of 16 – SEC Filing

Schedule 13G PAGE 12 of 16

CUSIP No. 24344T101

(g) [ ] Parent Holding Company, in accordance with Rule 13d-
1(b)(ii)(G)

(h) [ ] Savings Associations as defined in Section 3(b) of the
Federal Deposit Insurance Act

(i) [ ] Church Plan that is excluded from the definition of an
investment company under Section 3(c)(14) of the
Investment Company Act of 1940

(j) [ ] A non-U.S. institution in accordance with
Rule 240.13d-1(b)(1)(ii)(J)

(k) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
If filing as a non-U.S. institution in accordance with
Rule 240.13d-1(b)(1)(ii)(J), please specify
the type of institution:

ITEM 4. OWNERSHIP.

A. VGI
(a) Amount beneficially owned: 2,479,867
(b) Percent of class: 8.1%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote
0
(ii) shared power to vote or to direct the vote
2,479,867
(iii) sole power to dispose or to direct the disposition
of 0
(iv) shared power to dispose or to direct the disposition
of 2,479,867

VGI provides managerial services to Opportunities Fund,
Opportunities Intermediate and DRAGSA.
VGI has the authority to dispose of and vote the shares
of Common Stock. VGI does not directly own any shares of
Common Stock.

Based on Rule 13d-3 of the Securities Exchange Act of 1934,
as amended (the “Act”), VGI may be deemed to beneficially
own the shares of Common Stock directly held by Opportunities Fund,
Opportunities Intermediate and DRAGSA.

VGI beneficially owns 2,479,867 shares of Common Stock
consisting of (i) 988,325 shares of Common Stock directly
and beneficially owned by Opportunities Fund,
(ii) 821,238 shares of Common Stock directly and beneficially
owned by Opportunities Intermediate and (iii) 670,304 shares
of Common Stock directly and beneficially owned by DRAGSA.

Follow Deciphera Pharmaceuticals Inc. (NASDAQ:NA)

Page 12 of 16